Could Merck’s Molnupiravir and Pfizer’s Paxlovid, the Two New Anti-Viral Drugs Against COVID-19 Hasten the End of the Pandemic?

Could Merck’s Molnupiravir and Pfizer's Paxlovid, the Two New Anti-Viral Drugs Against COVID-19 Hasten the End of the Pandemic?

Could Merck’s Molnupiravir and Pfizer’s Paxlovid, the Two New Anti-Viral Drugs Against COVID-19 Hasten the End of the Pandemic?

Molnupiravir, the world’s first oral drug (approved by MHRA, UK) against COVID-19 along with upcoming drugs such as Paxlovid and sustained vaccination drive has raised hopes that the
#AntiviralDrug #COVID #COVID19 #Merck #Molnupiravir #Paxlovid #Pfizer
Umesh Prasad and Rajeev Soni

--

--

Editor, Scientific European SCIEU

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store